Urinary Phthalate Metabolite Concentrations and Diabetes among Women in the National Health and Nutrition Examination Survey (NHANES) 2001–2008

Background: Previous studies have shown that women have higher urinary concentrations of several phthalate metabolites than do men, possibly because of a higher use of personal care products. Few studies have evaluated the association between phthalate metabolites, diabetes, and diabetes-related risk factors among women. Objective: We explored the association between urinary phthalate metabolite concentrations and diabetes among women who participated in a cross-sectional study. Methods: We used urinary concentrations of phthalate metabolites, analyzed by the Centers for Disease Control and Prevention, and self-reported diabetes of 2,350 women between 20 and 79 years of age who participated in the NHANES (2001–2008). We used multiple logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs) and adjusted for urinary creatinine, sociodemographic characteristics, dietary factors, and body size. A secondary analysis was conducted for women who did not have diabetes to evaluate the association between phthalate metabolite concentrations and fasting blood glucose (FBG), homeostasis model assessment–estimated insulin resistance, and glycosylated hemoglobin A1c. Results: After adjusting for potential confounders, women with higher levels of mono-n-butyl phthalate (MnBP), mono-isobutyl phthalate (MiBP), monobenzyl phthalate (MBzP), mono-(3-carboxypropyl) phthalate (MCPP), and three di-(2-ethylhexyl) phthalate metabolites (ΣDEHP) had an increased odds of diabetes compared with women with the lowest levels of these phthalates. Women in the highest quartile for MBzP and MiBP had almost twice the odds of diabetes [OR = 1.96 (95% CI: 1.11, 3.47) and OR = 1.95 (95% CI: 0.99, 3.85), respectively] compared with women in the lowest quartile. Nonmonotonic, positive associations were found for MnBP and ΣDEHP, whereas MCPP appeared to have a threshold effect. Certain phthalate metabolites were positively associated with FBG and insulin resistance. Discussion: Urinary levels of several phthalates were associated with prevalent diabetes. Future prospective studies are needed to further explore these associations to determine whether phthalate exposure can alter glucose metabolism and increase the risk of insulin resistance and diabetes.

[1]  Michael A. Gallo,et al.  Role of Environmental Chemicals in Diabetes and Obesity: A National Toxicology Program Workshop Review , 2012, Environmental health perspectives.

[2]  S. Hernández-Díaz,et al.  Identification of Phthalates in Medications and Dietary Supplement Formulations in the United States and Canada , 2011, Environmental health perspectives.

[3]  Jerome P. Reiter,et al.  Exploratory quantile regression with many covariates: an application to adverse birth outcomes. , 2011, Epidemiology.

[4]  K. Svensson,et al.  Phthalate exposure associated with self-reported diabetes among Mexican women. , 2011, Environmental research.

[5]  A. Calafat,et al.  Personal care product use and urinary levels of phthalate metabolites in Mexican women. , 2011, Environment international.

[6]  W. Crinnion,et al.  Toxic effects of the easily avoidable phthalates and parabens. , 2010, Alternative medicine review : a journal of clinical therapeutic.

[7]  R. Newbold.  Impact of environmental endocrine disrupting chemicals on the development of obesity , 2010, Hormones.

[8]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2008. , 2010, JAMA.

[9]  Johan Auwerx,et al.  The Pollutant Diethylhexyl Phthalate Regulates Hepatic Energy Metabolism via Species-Specific PPARα-Dependent Mechanisms , 2009, Environmental health perspectives.

[10]  Ari B. Friedman,et al.  Diabetes prevalence and diagnosis in US states: analysis of health surveys , 2009, Population health metrics.

[11]  G. Latini,et al.  Influence of environment on insulin sensitivity. , 2009, Environment international.

[12]  Béatrice Desvergne,et al.  PPAR-mediated activity of phthalates: A link to the obesity epidemic? , 2009, Molecular and Cellular Endocrinology.

[13]  C. Casals-Casas,et al.  Interference of pollutants with PPARs: endocrine disruption meets metabolism , 2008, International Journal of Obesity.

[14]  Shanna H Swan,et al.  Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. , 2008, Environmental research.

[15]  Elizabeth E Hatch,et al.  Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999–2002 , 2008, Environmental health : a global access science source.

[16]  Elizabeth S. Spelke,et al.  Children’s understanding of the relationship between addition and subtraction , 2008, Cognition.

[17]  F. Grün,et al.  Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis , 2007, Reviews in Endocrine and Metabolic Disorders.

[18]  S. Swan,et al.  Concentrations of Urinary Phthalate Metabolites Are Associated with Increased Waist Circumference and Insulin Resistance in Adult U.S. Males , 2007, Environmental health perspectives.

[19]  Bernhard Liebl,et al.  Occurrence and daily variation of phthalate metabolites in the urine of an adult population. , 2007, International journal of hygiene and environmental health.

[20]  K. Balasubramanian,et al.  Diethylhexyl phthalate impairs insulin binding and glucose oxidation in Chang liver cells. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[21]  G. Latini.  Monitoring phthalate exposure in humans. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[22]  A. Calafat,et al.  PHTHALATES AND HUMAN HEALTH , 2005, Occupational and Environmental Medicine.

[23]  J. Corton,et al.  Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver. , 2005, Toxicology.

[24]  Samuel P. Caudill,et al.  Urinary Creatinine Concentrations in the U.S. Population: Implications for Urinary Biologic Monitoring Measurements , 2004, Environmental health perspectives.

[25]  A. Calafat,et al.  Medications as a source of human exposure to phthalates. , 2004, Environmental health perspectives.

[26]  C. R. Dhanya,et al.  Changes in some hormones by low doses of di (2-ethyl hexyl) phthalate (DEHP), a commonly used plasticizer in PVC blood storage bags & medical tubing. , 2004, The Indian journal of medical research.

[27]  Dana B Barr,et al.  Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. , 2003, Environmental health perspectives.

[28]  D. Waxman,et al.  Activation of PPARα and PPARγ by Environmental Phthalate Monoesters , 2003 .

[29]  C. Semenkovich,et al.  PPARα suppresses insulin secretion and induces UCP2 in insulinoma cells , 2002 .

[30]  D. Baird,et al.  Reproducibility of urinary phthalate metabolites in first morning urine samples. , 2002, Environmental health perspectives.

[31]  Paula Baillie-Hamilton.  Chemical toxins: a hypothesis to explain the global obesity epidemic. , 2002, Journal of alternative and complementary medicine.

[32]  M. Engelgau,et al.  Diabetes trends in the U.S.: 1990-1998. , 2000, Diabetes care.

[33]  J. Levy,et al.  Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes , 1999, Diabetologia.

[34]  T. Shoji,et al.  Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. , 1999, Diabetes care.

[35]  G. Colditz,et al.  Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in Women , 1995, Annals of Internal Medicine.

[36]  E L Korn,et al.  Epidemiologic studies utilizing surveys: accounting for the sampling design. , 1991, American journal of public health.

[37]  A. Calafat,et al.  Intra- and inter-individual variability of urinary phthalate metabolite concentrations in Hmong women of reproductive age , 2010, Journal of Exposure Science and Environmental Epidemiology.

[38]  G. Foster,et al.  The National Health and Nutrition Examination Survey , 2006 .

[39]  D. Waxman,et al.  Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[40]  C. Semenkovich,et al.  PPARalpha suppresses insulin secretion and induces UCP2 in insulinoma cells. , 2002, Journal of lipid research.

[41]  E. Bonora,et al.  Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. , 2000, Diabetes care.

[42]  이현철,et al.  Homeostasis Model Assessment법을 이용한 인슐린저항성 평가의 한계 , 2000 .

[43]  M. Harris.  Chapter 2 Classification , Diagnostic Criteria , and Screening for Diabetes , 1996 .